Navigation Links
Intermittent Catheter Market to Surpass 40% CAGR Between 2008 and 2012
Date:2/19/2009

New Medicare Reimbursement will have Significant Impact on the Intermittent Catheter Market, according to Millennium Research Group

WALTHAM, Mass., Feb. 19 /PRNewswire/ -- Millennium Research Group (MRG) has updated its US Markets for Urological Devices 2008 report to reflect momentous shifts in the US intermittent catheter market. Due mainly to a favorable upgrade in Medicare reimbursement, the US intermittent catheter market, comprising reusable straight strips, disposable gel-coated strips and trays, and disposable hydrophilic strips, will achieve a compound annual growth rate (CAGR) above 40% between 2008 and 2012.

Effective April 1, 2008, the number of intermittent catheters covered by Medicare increased from four per month to a maximum of 200 catheters per month, promoting single-use catheterization. One of the largest influences driving this change was the November 2007 recommendation from the Department of Veterans Affairs (VA) that its clinicians follow all manufacturer instructions for catheter use, ensuring that catheters classified as single use by manufacturers and the FDA are not reused. In order to provide consistency among government organizations, Medicare reimbursement was changed shortly following recommendations from the Department of VA.

"Also important was that on October 1, 2008, Medicare withdrew reimbursement to hospitals for treating certain conditions that were not present on admission, including catheter-associated urinary tract infections," says Lexie Code, Manager of the Endoscopy division at MRG. "Because intermittent strips are inserted only when the need to drain urine arises and therefore result in fewer infections, hospitals have an additional incentive to adopt these products, further driving market expansion."

MRG's US Markets for Urological Devices 2009 report provides a detailed qualitative and quantitative analysis of the new reimbursement, as well as numerous other urological device markets in the areas of incontinence, prostate cancer, stone management, benign prostatic hyperplasia (BPH), and erectile dysfunction (ED). Coverage of key industry competitors includes American Medical Systems, C.R. Bard, Caldera Medical, Cook Urological, Coloplast, Lumenis, Olympus, Richard Wolf, and many more.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters
2. St. Mary Medical Center Opens New Cardiovascular Catheterization Labs Reaffirming Role as a Regional Leader in Cardiovascular Medicine
3. Insightra Medical, Inc. Gains FDA clearance for the Most Complete Range of 7Fr Intra Aortic Balloon (IAB) Catheters
4. Avalon Laboratories receives FDA and European clearances to market 3 catheter devices
5. Avalon Laboratories receives FDA and European clearances to market three catheter devices
6. Innovative Atrial Fibrillation (AF) Catheter Ablation System From Ablation Frontiers is Subject of Two Abstracts at Heart Rhythm Congress UK
7. Concentric Medical Launches Distal Access Catheter
8. Clear Catheter Systems Completes $600-Million Financing, Opens Cleveland Office
9. OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter
10. Texas Jury Awards $250 Million Patent Infringement Verdict Against Boston Scientific in Balloon Catheter Lawsuit
11. Dialysis Catheter Placement Makes Little Difference in Infection Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... A book about the self-discovery of one’s limitless creative power, “ Unleash Your ... give readers the courage they need to embrace their creativity and unleash it as ... my life to learn and create what I set my heart with no limits ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... "ProDrop 3D ... projects to the next level," said Christina Austin - CEO of Pixel Film Studios. ... Studios. With ProDrop 3D Abstract have the ability to generate and manipulate three-dimensional shapes ...
(Date:5/31/2016)... ... ... According to recent statistics, there are nearly half a million physical therapists ... physical therapy professional and every clinic has a duty to perform at the highest ... competitive industry is also essential. The solution that many physical therapy leaders turn to ...
(Date:5/31/2016)... (PRWEB) , ... June 01, 2016 , ... ... “ Psoriasis and smoking: links and risks ”. , As corresponding author Professor ... on the relation between smoking habits and psoriasis. Smoking influences the onset and ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... that considers individuals’ genetic characteristics and the physical and behavioral worlds in ... in sync. In personalized medicine, diagnosing an individual’s disease depends on accurately ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... market growth is the emergence of new treatments. Cardax, ... therapies for osteoarthritis treatment. The therapy is expected to ... Arthritis Research UK is conducting studies to develop new ... study, where the genes involved in osteoarthritis are being ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... -- FDA 510(k) clearance covers Confocal ... urological and surgical applications Mauna Kea ... the multidisciplinary confocal laser endomicroscopy (CLE) platform, today ... with the 12 th 510(k) clearance from ... new FDA clearance covers Confocal Miniprobes indicated for ...
Breaking Medicine Technology: